News

Infectious Disease Point of Care Diagnostics Market to Witness Huge Growth by 2026| Abbott, Siemens, GE Healthcare

Infectious Disease Point of Care Diagnostics
Infectious Disease Point of Care Diagnostics

In a recent study published by QY Research, titled “Global Infectious Disease Point of Care Diagnostics Market Research Report”, analysts offer an in-depth analysis of the global Infectious Disease Point of Care Diagnostics market. The study analyzes the various aspects of the market by studying its historic and forecast data. The research report provides a Porters five force model, SWOT analysis, and PESTEL analysis of the Infectious Disease Point of Care Diagnostics market. The different areas covered in the report are Infectious Disease Point of Care Diagnostics market size, drivers and restraints, segment analysis, geographic outlook, major manufacturers in the market, competitive landscape, value/volume data, marketing strategies, and expert views

Major Key Player operating in this report are: Abbott, Siemens, GE Healthcare, Accriva, Terumo, BioMerieux, Diasorin, Roche, Danaher Corporation, BD, Bio-Rad Laboratories, Cavidi, Cepheid, Diaxonhit, Eiken Chemical, EMD Millipore, Epitope Diagnostic, Euroimmun, Gold Standard Diagnostics, Hologic, Immunetics, InBios International

Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :  

https://www.qyresearch.com/sample-form/form/1493507/global-infectious-disease-point-of-care-diagnostics-market

Segmental Analysis

The report has classified the global Infectious Disease Point of Care Diagnostics industry into segments including product type and application. Every segment is evaluated based on growth rate and share. Besides, the analysts have studied the potential regions that may prove rewarding for the Infectious Disease Point of Care Diagnostics manufacturers in the coming years. The regional analysis includes reliable predictions on value and volume, thereby helping market players to gain deep insights into the overall Infectious Disease Point of Care Diagnostics industry.

 Global Infectious Disease Point of Care Diagnostics Market Segment By Type:

Over-the-counter (OTC) Testing Kits
Prescription-based Testing Kits

Global Infectious Disease Point of Care Diagnostics Market Segment By Application:

Bacterial Infections
Fungal Infection
Virus Infection
Cardiovascular Infection
Gastrointestinal Infection
Sexually Transmitted Disease (STD) Infection
Central Nervous System Infection
Other

In terms of region, this research report covers almost all the major regions across the globe such as North America, Europe, South America, the Middle East, and Africa, and the Asia Pacific. Europe and North America regions are anticipated to show an upward growth in the years to come.  While Infectious Disease Point of Care Diagnostics market in Asia Pacific regions is likely to show remarkable growth during the forecasted period. Cutting edge technology and innovations are the most important traits of the North America region and that’s the reason most of the time the US dominates the global markets. The keyword market in the South, America region is also expected to grow in the near future.

Competitive Landscape

It is important for every market participant to be familiar with the competitive scenario in the global Infectious Disease Point of Care Diagnostics industry. In order to fulfil the requirements, the industry analysts have evaluated the strategic activities of the competitors to help the key players strengthen their foothold in the market and increase their competitiveness.

Key companies operating in the global Infectious Disease Point of Care Diagnostics market include:   Abbott, Siemens, GE Healthcare, Accriva, Terumo, BioMerieux, Diasorin, Roche, Danaher Corporation, BD, Bio-Rad Laboratories, Cavidi, Cepheid, Diaxonhit, Eiken Chemical, EMD Millipore, Epitope Diagnostic, Euroimmun, Gold Standard Diagnostics, Hologic, Immunetics, InBios International

Key questions answered in the report:

What is the growth potential of the Infectious Disease Point of Care Diagnostics market?

Which product segment will grab a lion’s share?

Which regional market will emerge as a frontrunner in the coming years?

Which application segment will grow at a robust rate?

What are the growth opportunities that may emerge in the Infectious Disease Point of Care Diagnostics industry in the years to come?

What are the key challenges that the global Infectious Disease Point of Care Diagnostics market may face in the future?

Which are the leading companies in the global Infectious Disease Point of Care Diagnostics market?

Which are the key trends positively impacting the market growth?

Which are the growth strategies considered by the players to sustain hold in the global Infectious Disease Point of Care Diagnostics  market

Reasons to buy this report:

QY Research report is designed in a method that assists clients to acquire a complete knowledge of the overall market scenario and the important sectors.

This report consists of a detailed overview of market dynamics and comprehensive research.

Explore further market opportunities and identify high potential categories based on detailed volume and value analysis

Detail information on competitive landscape, recent market trends and changing technologies that can be useful for the companies which are competing in this market

Gaining knowledge about competitive landscape based on detailed brand share analysis to plan an effective market positioning

Enquire Customization in the Report

https://www.qyresearch.com/customize-request/form/1493507/global-infectious-disease-point-of-care-diagnostics-market

Finally, the global Infectious Disease Point of Care Diagnostics Market is a valuable source of guidance for individuals and companies. One of the major reasons behind providing market attractiveness index is to help the target audience and clients to identify the several market opportunities in the global Infectious Disease Point of Care Diagnostics market. Moreover, for a better understanding of the market, QY Research has also presented a key to get information about various segments of the global Infectious Disease Point of Care Diagnostics market.

Tables of Content    

Table of Contents 1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Infectious Disease Point of Care Diagnostics Revenue
1.4 Market Analysis by Type
1.4.1 Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Over-the-counter (OTC) Testing Kits
1.4.3 Prescription-based Testing Kits
1.5 Market by Application
1.5.1 Global Infectious Disease Point of Care Diagnostics Market Share by Application: 2020 VS 2026
1.5.2 Bacterial Infections
1.5.3 Fungal Infection
1.5.4 Virus Infection
1.5.5 Cardiovascular Infection
1.5.6 Gastrointestinal Infection
1.5.7 Sexually Transmitted Disease (STD) Infection
1.5.8 Central Nervous System Infection
1.5.9 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions
2.1 Infectious Disease Point of Care Diagnostics Market Perspective (2015-2026)
2.2 Infectious Disease Point of Care Diagnostics Growth Trends by Regions
2.2.1 Infectious Disease Point of Care Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Infectious Disease Point of Care Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Infectious Disease Point of Care Diagnostics Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Infectious Disease Point of Care Diagnostics Market Growth Strategy
2.3.6 Primary Interviews with Key Infectious Disease Point of Care Diagnostics Players (Opinion Leaders) 3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease Point of Care Diagnostics Players by Market Size
3.1.1 Global Top Infectious Disease Point of Care Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Players (2015-2020)
3.1.3 Global Infectious Disease Point of Care Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Infectious Disease Point of Care Diagnostics Market Concentration Ratio
3.2.1 Global Infectious Disease Point of Care Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Infectious Disease Point of Care Diagnostics Revenue in 2019
3.3 Infectious Disease Point of Care Diagnostics Key Players Head office and Area Served
3.4 Key Players Infectious Disease Point of Care Diagnostics Product Solution and Service
3.5 Date of Enter into Infectious Disease Point of Care Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026)
4.1 Global Infectious Disease Point of Care Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Type (2021-2026) 5 Infectious Disease Point of Care Diagnostics Breakdown Data by Application (2015-2026)
5.1 Global Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
5.2 Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Application (2021-2026) 6 North America
6.1 North America Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
6.2 Infectious Disease Point of Care Diagnostics Key Players in North America (2019-2020)
6.3 North America Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
6.4 North America Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) 7 Europe
7.1 Europe Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
7.2 Infectious Disease Point of Care Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
7.4 Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) 8 China
8.1 China Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
8.2 Infectious Disease Point of Care Diagnostics Key Players in China (2019-2020)
8.3 China Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
8.4 China Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) 9 Japan
9.1 Japan Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
9.2 Infectious Disease Point of Care Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
9.4 Japan Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) 10 Southeast Asia
10.1 Southeast Asia Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
10.2 Infectious Disease Point of Care Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) 11 India
11.1 India Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
11.2 Infectious Disease Point of Care Diagnostics Key Players in India (2019-2020)
11.3 India Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
11.4 India Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) 12 Central & South America
12.1 Central & South America Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
12.2 Infectious Disease Point of Care Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) 13Key Players Profiles
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview and Its Total Revenue
13.1.3 Abbott Infectious Disease Point of Care Diagnostics Introduction
13.1.4 Abbott Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 Siemens
13.2.1 Siemens Company Details
13.2.2 Siemens Business Overview and Its Total Revenue
13.2.3 Siemens Infectious Disease Point of Care Diagnostics Introduction
13.2.4 Siemens Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.2.5 Siemens Recent Development
13.3 GE Healthcare
13.3.1 GE Healthcare Company Details
13.3.2 GE Healthcare Business Overview and Its Total Revenue
13.3.3 GE Healthcare Infectious Disease Point of Care Diagnostics Introduction
13.3.4 GE Healthcare Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.3.5 GE Healthcare Recent Development
13.4 Accriva
13.4.1 Accriva Company Details
13.4.2 Accriva Business Overview and Its Total Revenue
13.4.3 Accriva Infectious Disease Point of Care Diagnostics Introduction
13.4.4 Accriva Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.4.5 Accriva Recent Development
13.5 Terumo
13.5.1 Terumo Company Details
13.5.2 Terumo Business Overview and Its Total Revenue
13.5.3 Terumo Infectious Disease Point of Care Diagnostics Introduction
13.5.4 Terumo Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.5.5 Terumo Recent Development
13.6 BioMerieux
13.6.1 BioMerieux Company Details
13.6.2 BioMerieux Business Overview and Its Total Revenue
13.6.3 BioMerieux Infectious Disease Point of Care Diagnostics Introduction
13.6.4 BioMerieux Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.6.5 BioMerieux Recent Development
13.7 Diasorin
13.7.1 Diasorin Company Details
13.7.2 Diasorin Business Overview and Its Total Revenue
13.7.3 Diasorin Infectious Disease Point of Care Diagnostics Introduction
13.7.4 Diasorin Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.7.5 Diasorin Recent Development
13.8 Roche
13.8.1 Roche Company Details
13.8.2 Roche Business Overview and Its Total Revenue
13.8.3 Roche Infectious Disease Point of Care Diagnostics Introduction
13.8.4 Roche Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.8.5 Roche Recent Development
13.9 Danaher Corporation
13.9.1 Danaher Corporation Company Details
13.9.2 Danaher Corporation Business Overview and Its Total Revenue
13.9.3 Danaher Corporation Infectious Disease Point of Care Diagnostics Introduction
13.9.4 Danaher Corporation Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.9.5 Danaher Corporation Recent Development
13.10 BD
13.10.1 BD Company Details
13.10.2 BD Business Overview and Its Total Revenue
13.10.3 BD Infectious Disease Point of Care Diagnostics Introduction
13.10.4 BD Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.10.5 BD Recent Development
13.11 Bio-Rad Laboratories
10.11.1 Bio-Rad Laboratories Company Details
10.11.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
10.11.3 Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Introduction
10.11.4 Bio-Rad Laboratories Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.11.5 Bio-Rad Laboratories Recent Development
13.12 Cavidi
10.12.1 Cavidi Company Details
10.12.2 Cavidi Business Overview and Its Total Revenue
10.12.3 Cavidi Infectious Disease Point of Care Diagnostics Introduction
10.12.4 Cavidi Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.12.5 Cavidi Recent Development
13.13 Cepheid
10.13.1 Cepheid Company Details
10.13.2 Cepheid Business Overview and Its Total Revenue
10.13.3 Cepheid Infectious Disease Point of Care Diagnostics Introduction
10.13.4 Cepheid Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.13.5 Cepheid Recent Development
13.14 Diaxonhit
10.14.1 Diaxonhit Company Details
10.14.2 Diaxonhit Business Overview and Its Total Revenue
10.14.3 Diaxonhit Infectious Disease Point of Care Diagnostics Introduction
10.14.4 Diaxonhit Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.14.5 Diaxonhit Recent Development
13.15 Eiken Chemical
10.15.1 Eiken Chemical Company Details
10.15.2 Eiken Chemical Business Overview and Its Total Revenue
10.15.3 Eiken Chemical Infectious Disease Point of Care Diagnostics Introduction
10.15.4 Eiken Chemical Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.15.5 Eiken Chemical Recent Development
13.16 EMD Millipore
10.16.1 EMD Millipore Company Details
10.16.2 EMD Millipore Business Overview and Its Total Revenue
10.16.3 EMD Millipore Infectious Disease Point of Care Diagnostics Introduction
10.16.4 EMD Millipore Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.16.5 EMD Millipore Recent Development
13.17 Epitope Diagnostic
10.17.1 Epitope Diagnostic Company Details
10.17.2 Epitope Diagnostic Business Overview and Its Total Revenue
10.17.3 Epitope Diagnostic Infectious Disease Point of Care Diagnostics Introduction
10.17.4 Epitope Diagnostic Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.17.5 Epitope Diagnostic Recent Development
13.18 Euroimmun
10.18.1 Euroimmun Company Details
10.18.2 Euroimmun Business Overview and Its Total Revenue
10.18.3 Euroimmun Infectious Disease Point of Care Diagnostics Introduction
10.18.4 Euroimmun Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.18.5 Euroimmun Recent Development
13.19 Gold Standard Diagnostics
10.19.1 Gold Standard Diagnostics Company Details
10.19.2 Gold Standard Diagnostics Business Overview and Its Total Revenue
10.19.3 Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Introduction
10.19.4 Gold Standard Diagnostics Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.19.5 Gold Standard Diagnostics Recent Development
13.20 Hologic
10.20.1 Hologic Company Details
10.20.2 Hologic Business Overview and Its Total Revenue
10.20.3 Hologic Infectious Disease Point of Care Diagnostics Introduction
10.20.4 Hologic Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.20.5 Hologic Recent Development
13.21 Immunetics
10.21.1 Immunetics Company Details
10.21.2 Immunetics Business Overview and Its Total Revenue
10.21.3 Immunetics Infectious Disease Point of Care Diagnostics Introduction
10.21.4 Immunetics Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.21.5 Immunetics Recent Development
13.22 InBios International
10.22.1 InBios International Company Details
10.22.2 InBios International Business Overview and Its Total Revenue
10.22.3 InBios International Infectious Disease Point of Care Diagnostics Introduction
10.22.4 InBios International Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.22.5 InBios International Recent Development 14Analyst’s Viewpoints/Conclusions 15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

About Us:

 QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from a huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.